Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 711

1.

Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.

Schuepbach WMM, Tonder L, Schnitzler A, Krack P, Rau J, Hartmann A, Hälbig T, Pineau F, Falk A, Paschen L, Paschen S, Volkmann J, Dafsari HS, Barbe MT, Fink GR, Kühn A, Kupsch A, Schneider GH, Seigneuret E, Fraix V, Kistner A, Chaynes PP, Ory-Magne F, Brefel-Courbon C, Vesper J, Wojtecki L, Derrey S, Maltête D, Damier P, Derkinderen P, Sixel-Döring F, Trenkwalder C, Gharabaghi A, Wächter T, Weiss D, Pinsker MO, Regis JM, Witjas T, Thobois S, Mertens P, Knudsen K, Schade-Brittinger C, Houeto JL, Agid Y, Vidailhet M, Timmermann L, Deuschl G; EARLYSTIM study group.

Neurology. 2019 Feb 8. pii: 10.1212/WNL.0000000000007037. doi: 10.1212/WNL.0000000000007037. [Epub ahead of print]

PMID:
30737338
2.

Foreword. History of the frontal lobe.

Bossi L, Agid Y; scientific committee.

Rev Neurol (Paris). 2018 Dec;174(10):736. doi: 10.1016/j.neurol.2018.09.012. Epub 2018 Sep 28. No abstract available.

PMID:
30274816
3.

At the Origin of the History of Glia.

Fan X, Agid Y.

Neuroscience. 2018 Aug 10;385:255-271. doi: 10.1016/j.neuroscience.2018.05.050. Epub 2018 Jun 8. Review.

PMID:
29890289
4.

Progress in the neurosciences and the training of medical students.

Agid Y.

Rev Neurol (Paris). 2018 Mar;174(3):102-103. doi: 10.1016/j.neurol.2017.06.006. Epub 2018 Jan 9. No abstract available.

PMID:
29329751
5.

Introduction.

Bossi L, Agid Y; Scientific Committee.

Rev Neurol (Paris). 2017 Dec;173(10):601. doi: 10.1016/j.neurol.2017.11.001. No abstract available.

PMID:
29179836
6.

Behavior, brain and astrocytes.

Fan X, Agid Y.

Rev Neurol (Paris). 2017 Dec;173(10):619-622. doi: 10.1016/j.neurol.2017.05.017. Epub 2017 Jun 23. Review. No abstract available.

PMID:
28651784
7.

Anterior pallidal deep brain stimulation for Tourette's syndrome: a randomised, double-blind, controlled trial.

Welter ML, Houeto JL, Thobois S, Bataille B, Guenot M, Worbe Y, Hartmann A, Czernecki V, Bardinet E, Yelnik J, du Montcel ST, Agid Y, Vidailhet M, Cornu P, Tanguy A, Ansquer S, Jaafari N, Poulet E, Serra G, Burbaud P, Cuny E, Aouizerate B, Pollak P, Chabardes S, Polosan M, Borg M, Fontaine D, Giordana B, Raoul S, Rouaud T, Sauvaget A, Jalenques I, Karachi C, Mallet L; STIC study group.

Lancet Neurol. 2017 Aug;16(8):610-619. doi: 10.1016/S1474-4422(17)30160-6. Epub 2017 Jun 20.

PMID:
28645853
8.

Subconsciousness, emotional disorders, and basal ganglia.

Agid Y.

Rev Neurol (Paris). 2017 Mar;173(3):101-102. doi: 10.1016/j.neurol.2016.12.029. Epub 2017 Mar 11. No abstract available.

PMID:
28291532
9.

Commentary: Dealing with the Aftermath.

Agid Y.

Camb Q Healthc Ethics. 2016 Oct;25(4):750-1. doi: 10.1017/S0963180116000505.

PMID:
27634725
10.

The Concept of Subconsciousness in Alzheimer's and Parkinson's Diseases.

Agid Y.

J Parkinsons Dis. 2015;5(3):643-5. doi: 10.3233/JPD-150573. Review. No abstract available.

PMID:
26406145
11.

Tourette syndrome deep brain stimulation: a review and updated recommendations.

Schrock LE, Mink JW, Woods DW, Porta M, Servello D, Visser-Vandewalle V, Silburn PA, Foltynie T, Walker HC, Shahed-Jimenez J, Savica R, Klassen BT, Machado AG, Foote KD, Zhang JG, Hu W, Ackermans L, Temel Y, Mari Z, Changizi BK, Lozano A, Auyeung M, Kaido T, Agid Y, Welter ML, Khandhar SM, Mogilner AY, Pourfar MH, Walter BL, Juncos JL, Gross RE, Kuhn J, Leckman JF, Neimat JA, Okun MS; Tourette Syndrome Association International Deep Brain Stimulation (DBS) Database and Registry Study Group.

Mov Disord. 2015 Apr;30(4):448-71. doi: 10.1002/mds.26094. Epub 2014 Dec 5. Review.

PMID:
25476818
12.

Optimal target localization for subthalamic stimulation in patients with Parkinson disease.

Welter ML, Schüpbach M, Czernecki V, Karachi C, Fernandez-Vidal S, Golmard JL, Serra G, Navarro S, Welaratne A, Hartmann A, Mesnage V, Pineau F, Cornu P, Pidoux B, Worbe Y, Zikos P, Grabli D, Galanaud D, Bonnet AM, Belaid H, Dormont D, Vidailhet M, Mallet L, Houeto JL, Bardinet E, Yelnik J, Agid Y.

Neurology. 2014 Apr 15;82(15):1352-61. doi: 10.1212/WNL.0000000000000315. Epub 2014 Mar 19.

13.

High-level gait and balance disorders in the elderly: a midbrain disease?

Demain A, Westby GW, Fernandez-Vidal S, Karachi C, Bonneville F, Do MC, Delmaire C, Dormont D, Bardinet E, Agid Y, Chastan N, Welter ML.

J Neurol. 2014 Jan;261(1):196-206. doi: 10.1007/s00415-013-7174-x. Epub 2013 Nov 8.

14.

Subthalamic neurostimulation for Parkinson's disease with early fluctuations: balancing the risks and benefits.

Deuschl G, Agid Y.

Lancet Neurol. 2013 Oct;12(10):1025-34. doi: 10.1016/S1474-4422(13)70151-0. Review.

PMID:
24050735
15.

Subconscious man: the basal ganglia as a target for intervention in emotional disorders.

Agid Y.

Ann Neurol. 2013 Dec;74(6):920-2. doi: 10.1002/ana.24013. No abstract available.

PMID:
24038397
16.

[Understanding how the brain functions and dysfunctions].

Agid Y.

Rev Prat. 2013 May;63(5):631-3. French. No abstract available.

PMID:
23789486
17.

Neurostimulation for Parkinson's disease with early motor complications.

Deuschl G, Schade-Brittinger C, Agid Y; EARLYSTIM Study Group.

N Engl J Med. 2013 May 23;368(21):2038. doi: 10.1056/NEJMc1303485. No abstract available.

PMID:
23697520
18.

Neurostimulation for Parkinson's disease with early motor complications.

Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, Hälbig TD, Hesekamp H, Navarro SM, Meier N, Falk D, Mehdorn M, Paschen S, Maarouf M, Barbe MT, Fink GR, Kupsch A, Gruber D, Schneider GH, Seigneuret E, Kistner A, Chaynes P, Ory-Magne F, Brefel Courbon C, Vesper J, Schnitzler A, Wojtecki L, Houeto JL, Bataille B, Maltête D, Damier P, Raoul S, Sixel-Doering F, Hellwig D, Gharabaghi A, Krüger R, Pinsker MO, Amtage F, Régis JM, Witjas T, Thobois S, Mertens P, Kloss M, Hartmann A, Oertel WH, Post B, Speelman H, Agid Y, Schade-Brittinger C, Deuschl G; EARLYSTIM Study Group.

N Engl J Med. 2013 Feb 14;368(7):610-22. doi: 10.1056/NEJMoa1205158.

19.

Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study.

Deuschl G, Schüpbach M, Knudsen K, Pinsker MO, Cornu P, Rau J, Agid Y, Schade-Brittinger C.

Parkinsonism Relat Disord. 2013 Jan;19(1):56-61. doi: 10.1016/j.parkreldis.2012.07.004. Epub 2012 Jul 28.

PMID:
22841616
20.

Does unilateral basal ganglia activity functionally influence the contralateral side? What we can learn from STN stimulation in patients with Parkinson's disease.

Brun Y, Karachi C, Fernandez-Vidal S, Jodoin N, Grabli D, Bardinet E, Mallet L, Agid Y, Yelnik J, Welter ML.

J Neurophysiol. 2012 Sep;108(6):1575-83. doi: 10.1152/jn.00254.2012. Epub 2012 Jun 27.

21.

Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy.

Millan MJ, Agid Y, Brüne M, Bullmore ET, Carter CS, Clayton NS, Connor R, Davis S, Deakin B, DeRubeis RJ, Dubois B, Geyer MA, Goodwin GM, Gorwood P, Jay TM, Joëls M, Mansuy IM, Meyer-Lindenberg A, Murphy D, Rolls E, Saletu B, Spedding M, Sweeney J, Whittington M, Young LJ.

Nat Rev Drug Discov. 2012 Feb 1;11(2):141-68. doi: 10.1038/nrd3628. Review.

PMID:
22293568
22.

The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United Kingdom.

McCrone P, Payan CA, Knapp M, Ludolph A, Agid Y, Leigh PN, Bensimon G; NNIPPS Study Group.

PLoS One. 2011;6(9):e24369. doi: 10.1371/journal.pone.0024369. Epub 2011 Sep 8.

23.

Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus Scale.

Payan CA, Viallet F, Landwehrmeyer BG, Bonnet AM, Borg M, Durif F, Lacomblez L, Bloch F, Verny M, Fermanian J, Agid Y, Ludolph AC, Leigh PN, Bensimon G; NNIPPS Study Group.

PLoS One. 2011;6(8):e22293. doi: 10.1371/journal.pone.0022293. Epub 2011 Aug 4.

24.

Unilateral thalamic deep brain stimulation for disabling kinetic tremor in multiple sclerosis.

Hosseini H, Mandat T, Waubant E, Agid Y, Lubetzki C, Lyon-Caen O, Stankoff B, Jedynak P, Cesaro P, Palfi S, Nguyen JP.

Neurosurgery. 2012 Jan;70(1):66-9. doi: 10.1227/NEU.0b013e31822da55c.

PMID:
21768914
25.

Movement Disorders, the journal, and movement disorders, the field?

Agid Y.

Mov Disord. 2011 May;26(6):937-8. doi: 10.1002/mds.23780. Review. No abstract available.

PMID:
21626539
26.

The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial.

Corvol JC, Bonnet C, Charbonnier-Beaupel F, Bonnet AM, Fiévet MH, Bellanger A, Roze E, Meliksetyan G, Ben Djebara M, Hartmann A, Lacomblez L, Vrignaud C, Zahr N, Agid Y, Costentin J, Hulot JS, Vidailhet M.

Ann Neurol. 2011 Jan;69(1):111-8. doi: 10.1002/ana.22155.

PMID:
21280081
27.

Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease.

Redgrave P, Rodriguez M, Smith Y, Rodriguez-Oroz MC, Lehericy S, Bergman H, Agid Y, DeLong MR, Obeso JA.

Nat Rev Neurosci. 2010 Nov;11(11):760-72. doi: 10.1038/nrn2915. Epub 2010 Oct 14. Review.

28.

Repetitive behaviours in patients with Gilles de la Tourette syndrome: tics, compulsions, or both?

Worbe Y, Mallet L, Golmard JL, Béhar C, Durif F, Jalenques I, Damier P, Derkinderen P, Pollak P, Anheim M, Broussolle E, Xie J, Mesnage V, Mondon K, Viallet F, Jedynak P, Ben Djebara M, Schüpbach M, Pelissolo A, Vidailhet M, Agid Y, Houeto JL, Hartmann A.

PLoS One. 2010 Sep 24;5(9):e12959. doi: 10.1371/journal.pone.0012959.

29.

[Parkinson's diseases: power of search].

Agid Y.

Rev Neurol (Paris). 2010 Oct;166(10):755. doi: 10.1016/j.neurol.2010.07.011. French. No abstract available.

PMID:
20801469
30.

Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.

Brown RG, Lacomblez L, Landwehrmeyer BG, Bak T, Uttner I, Dubois B, Agid Y, Ludolph A, Bensimon G, Payan C, Leigh NP; NNIPPS Study Group.

Brain. 2010 Aug;133(Pt 8):2382-93. doi: 10.1093/brain/awq158. Epub 2010 Jun 24.

PMID:
20576697
31.

Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.

Moro E, Lozano AM, Pollak P, Agid Y, Rehncrona S, Volkmann J, Kulisevsky J, Obeso JA, Albanese A, Hariz MI, Quinn NP, Speelman JD, Benabid AL, Fraix V, Mendes A, Welter ML, Houeto JL, Cornu P, Dormont D, Tornqvist AL, Ekberg R, Schnitzler A, Timmermann L, Wojtecki L, Gironell A, Rodriguez-Oroz MC, Guridi J, Bentivoglio AR, Contarino MF, Romito L, Scerrati M, Janssens M, Lang AE.

Mov Disord. 2010 Apr 15;25(5):578-86. doi: 10.1002/mds.22735.

PMID:
20213817
32.

Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study.

Rascol O, Azulay JP, Blin O, Bonnet AM, Brefel-Courbon C, Césaro P, Damier P, Debilly B, Durif F, Galitzky M, Grouin JM, Pennaforte S, Villafane G, Yaici S, Agid Y.

Mov Disord. 2010 Feb 15;25(3):368-76. doi: 10.1002/mds.22922.

PMID:
20063435
33.

Influence of sensory inputs and motor demands on the control of the centre of mass velocity during gait initiation in humans.

Chastan N, Westby GW, du Montcel ST, Do MC, Chong RK, Agid Y, Welter ML.

Neurosci Lett. 2010 Jan 29;469(3):400-4. doi: 10.1016/j.neulet.2009.12.038. Epub 2009 Dec 22.

PMID:
20026383
34.

Periodic leg movements and REM sleep without atonia in Parkinson's disease with camptocormia.

Lavault S, Bloch F, Houeto JL, Konofal E, Welter ML, Agid Y, Arnulf I.

Mov Disord. 2009 Dec 15;24(16):2419-23. doi: 10.1002/mds.22854.

PMID:
19891002
35.

Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy.

Al-Chalabi A, Dürr A, Wood NW, Parkinson MH, Camuzat A, Hulot JS, Morrison KE, Renton A, Sussmuth SD, Landwehrmeyer BG, Ludolph A, Agid Y, Brice A, Leigh PN, Bensimon G; NNIPPS Genetic Study Group.

PLoS One. 2009 Sep 22;4(9):e7114. doi: 10.1371/journal.pone.0007114.

36.

Perspectives on recent advances in the understanding and treatment of Parkinson's disease.

Schapira AH, Agid Y, Barone P, Jenner P, Lemke MR, Poewe W, Rascol O, Reichmann H, Tolosa E.

Eur J Neurol. 2009 Oct;16(10):1090-9. doi: 10.1111/j.1468-1331.2009.02793.x. Epub 2009 Aug 30. Review.

PMID:
19723294
37.

Segmental progression of early untreated Parkinson's disease: a novel approach to clinical rating.

Schüpbach WM, Corvol JC, Czernecki V, Djebara MB, Golmard JL, Agid Y, Hartmann A.

J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):20-5. doi: 10.1136/jnnp.2008.159699. Epub 2009 Jul 20.

PMID:
19622523
38.

A multitracer dopaminergic PET study of young-onset parkinsonian patients with and without parkin gene mutations.

Ribeiro MJ, Thobois S, Lohmann E, du Montcel ST, Lesage S, Pelissolo A, Dubois B, Mallet L, Pollak P, Agid Y, Broussolle E, Brice A, Remy P; French Parkinson's Disease Genetics Study Group.

J Nucl Med. 2009 Aug;50(8):1244-50. doi: 10.2967/jnumed.109.063529. Epub 2009 Jul 17.

39.

Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot study.

Vidailhet M, Yelnik J, Lagrange C, Fraix V, Grabli D, Thobois S, Burbaud P, Welter ML, Xie-Brustolin J, Braga MC, Ardouin C, Czernecki V, Klinger H, Chabardes S, Seigneuret E, Mertens P, Cuny E, Navarro S, Cornu P, Benabid AL, Le Bas JF, Dormont D, Hermier M, Dujardin K, Blond S, Krystkowiak P, Destée A, Bardinet E, Agid Y, Krack P, Broussolle E, Pollak P; French SPIDY-2 Study Group.

Lancet Neurol. 2009 Aug;8(8):709-17. doi: 10.1016/S1474-4422(09)70151-6. Epub 2009 Jul 1.

PMID:
19576854
40.

Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease.

Volkmann J, Albanese A, Kulisevsky J, Tornqvist AL, Houeto JL, Pidoux B, Bonnet AM, Mendes A, Benabid AL, Fraix V, Van Blercom N, Xie J, Obeso J, Rodriguez-Oroz MC, Guridi J, Schnitzler A, Timmermann L, Gironell AA, Molet J, Pascual-Sedano B, Rehncrona S, Moro E, Lang AC, Lozano AM, Bentivoglio AR, Scerrati M, Contarino MF, Romito L, Janssens M, Agid Y.

Mov Disord. 2009 Jun 15;24(8):1154-61. doi: 10.1002/mds.22496.

PMID:
19412954
41.

Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms.

Ibáñez P, Lesage S, Janin S, Lohmann E, Durif F, Destée A, Bonnet AM, Brefel-Courbon C, Heath S, Zelenika D, Agid Y, Dürr A, Brice A; French Parkinson's Disease Genetics Study Group.

Arch Neurol. 2009 Jan;66(1):102-8. doi: 10.1001/archneurol.2008.555.

PMID:
19139307
42.

Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study.

Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN; NNIPPS Study Group.

Brain. 2009 Jan;132(Pt 1):156-71. doi: 10.1093/brain/awn291. Epub 2008 Nov 23.

43.

Subthalamic nucleus stimulation in severe obsessive-compulsive disorder.

Mallet L, Polosan M, Jaafari N, Baup N, Welter ML, Fontaine D, du Montcel ST, Yelnik J, Chéreau I, Arbus C, Raoul S, Aouizerate B, Damier P, Chabardès S, Czernecki V, Ardouin C, Krebs MO, Bardinet E, Chaynes P, Burbaud P, Cornu P, Derost P, Bougerol T, Bataille B, Mattei V, Dormont D, Devaux B, Vérin M, Houeto JL, Pollak P, Benabid AL, Agid Y, Krack P, Millet B, Pelissolo A; STOC Study Group.

N Engl J Med. 2008 Nov 13;359(20):2121-34. doi: 10.1056/NEJMoa0708514. Erratum in: N Engl J Med. 2009 Sep 3;361(10):1027.

44.

Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.

Chastan N, Westby GW, Yelnik J, Bardinet E, Do MC, Agid Y, Welter ML.

Brain. 2009 Jan;132(Pt 1):172-84. doi: 10.1093/brain/awn294. Epub 2008 Nov 11.

PMID:
19001482
45.

A multidisciplinary study of patients with early-onset PD with and without parkin mutations.

Lohmann E, Thobois S, Lesage S, Broussolle E, du Montcel ST, Ribeiro MJ, Remy P, Pelissolo A, Dubois B, Mallet L, Pollak P, Agid Y, Brice A; French Parkinson's Disease Genetics Study Group.

Neurology. 2009 Jan 13;72(2):110-6. doi: 10.1212/01.wnl.0000327098.86861.d4. Epub 2008 Nov 5.

46.

A three-dimensional histological atlas of the human basal ganglia. II. Atlas deformation strategy and evaluation in deep brain stimulation for Parkinson disease.

Bardinet E, Bhattacharjee M, Dormont D, Pidoux B, Malandain G, Schüpbach M, Ayache N, Cornu P, Agid Y, Yelnik J.

J Neurosurg. 2009 Feb;110(2):208-19. doi: 10.3171/2008.3.17469.

PMID:
18976051
47.

Gait and balance disorders in Parkinson's disease: impaired active braking of the fall of centre of gravity.

Chastan N, Do MC, Bonneville F, Torny F, Bloch F, Westby GW, Dormont D, Agid Y, Welter ML.

Mov Disord. 2009 Jan 30;24(2):188-95. doi: 10.1002/mds.22269.

PMID:
18973252
48.

[Can subthalamic nucleus stimulation reveal parkinsonian rest tremor?].

El Otmani H, Jodoin N, Yaici S, Welter ML, Bonnet AM, Navarro S, Pidoux B, Dormont D, Cornu P, Agid Y.

Rev Neurol (Paris). 2009 Jan;165(1):81-5. doi: 10.1016/j.neurol.2008.05.002. Epub 2008 Jul 7. French.

PMID:
18808774
49.

Contrasting changes in cortical activation induced by acute high-frequency stimulation within the globus pallidus in Parkinson's disease.

Payoux P, Remy P, Miloudi M, Houeto JL, Stadler C, Bejjani BP, Yelnik J, Samson Y, Rascol O, Agid Y, Damier P.

J Cereb Blood Flow Metab. 2009 Feb;29(2):235-43. doi: 10.1038/jcbfm.2008.107. Epub 2008 Sep 10.

PMID:
18781162
50.

A clinical, neuropsychological and olfactory evaluation of a large family with LRRK2 mutations.

Lohmann E, Leclere L, De Anna F, Lesage S, Dubois B, Agid Y, Dürr A, Brice A; French Parkinson's Disease Genetics Study Group.

Parkinsonism Relat Disord. 2009 May;15(4):273-6. doi: 10.1016/j.parkreldis.2008.06.008. Epub 2008 Aug 21.

PMID:
18718805

Supplemental Content

Support Center